Chinese drug maker 3SBio has licensed its new cancer drug to US pharmaceutical giant Pfizer in the largest deal ever…
Read More »Jefferies analysts
“In Hong Kong, the market experienced a slower-than-expected recovery in the first half of the year,” Hang Lung said in…
Read More »